BMS-833923 (XL-139) 50mg 50mg | Purity Not Available
Adooq Bioscience
BMS-833923 (or XL-139) is an orally bioavailable small-molecule SMO (Smoothened) inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-833923 (or XL-139) is an orally bioavailable small-molecule SMO (Smoothened) inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-833923 (or XL-139) is an orally bioavailable small-molecule SMO (Smoothened) inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-833923 (or XL-139) is an orally bioavailable small-molecule SMO (Smoothened) inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-833923 (or XL-139) is an orally bioavailable small-molecule SMO (Smoothened) inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-833923 (or XL-139) is an orally bioavailable small-molecule SMO (Smoothened) inhibitor with potential antineoplastic activity.
More Information Supplier PageAZD1208 is orally available, small molecule inhibitor of PIM kinases with potential antineoplastic activity.
More Information Supplier PageAZD1208 is orally available, small molecule inhibitor of PIM kinases with potential antineoplastic activity.
More Information Supplier PageUNC-0631 is a novel G9a inhibitor with excellent potency in a variety of cell lines and excellent separation of functional potency versus cell toxicity.
More Information Supplier PageUNC-0631 is a novel G9a inhibitor with excellent potency in a variety of cell lines and excellent separation of functional potency versus cell toxicity.
More Information Supplier PageUNC-0631 is a novel G9a inhibitor with excellent potency in a variety of cell lines and excellent separation of functional potency versus cell toxicity.
More Information Supplier Page